MedTrace Logo

Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

NCT05179616 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-09-22

No results posted yet for this study

Summary

The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.

Conditions

  • Tricuspid Regurgitation
  • Right Heart Failure
  • Cardiac Remodeling, Ventricular
  • Cardiac Remodeling, Atrial

Interventions

PROCEDURE

Transcatheter edge-to-edge tricuspid valve repair

Percutaneous edge to edge repair of tricuspid valve using the TriClip system

Sponsors & Collaborators

  • Helios Klinikum Pforzheim

    lead OTHER

Principal Investigators

  • Ilka Ott, MD, PhD · Helios Klinikum Pforzheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2025-11-30
Completion
2026-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05179616 on ClinicalTrials.gov